• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

RCPT:US

39.1100 USD 0.8800 2.30%

As of 20:10:00 ET on 07/25/2014.

Snapshot for Receptos Inc (RCPT)

Open: 37.9200 Day's Range: 37.3700 - 39.1200 Volume: 253,693
Previous Close: 38.2300 52wk Range: 15.2100 - 55.0000 1-Yr Rtn: +104.55%

Stock Chart for RCPT

No chart data available.
  • RCPT:US 39.1100
  • 1D
  • 1M
  • 1Y
38.2300
Interactive RCPT Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for RCPT

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -3.7300
Est. EPS (USD) (12/2014) -4.1080
Est. PEG Ratio -
Market Cap (M USD) 1,040.69
Shares Outstanding (M) 26.61
30 Day Average Volume 512,959
Price/Book (mrq) 6.1481
Price/Sale (ttm) 133.2401
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/07/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for RCPT

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for RCPT

Receptos, Inc. discovers and develops small molecule drug therapies. The Company specializes in the development of G protein-coupled receptors therapeutic candidates in the United States. Receptos focuses on the discovery, development, and commercialization of various therapeutics for immune disorders.

Faheem HasnainPresident/CEOGraham K CooperChief Financial Officer
Marcus F BoehmChief Technology OfficerRobert J PeachChief Scientific Officer
More Company Profile & Key Executives for RCPT

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil